Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03777371

Enrollment

128

Registered

2018-12-17

Start date

2014-01-01

Completion date

2018-12-01

Last updated

2018-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Pregnancy, High Risk

Brief summary

HIV virus is an etiologic agent of ( AIDS ) immunodeficiency syndrome . It is known that the estimated rate of transfer from mother to baby is 25% to 45%, pregnancy rate is 5-10%, pregnancy rate is 15-20% and in lactation period is 5-10%. Risk factors; maternal viral load, breastfeeding, vaginal birth, and prematurity. Although there is a high rate of false positivity in prenatal screening in our country, one of the factors affecting this is the number of pregnancies.

Interventions

OTHERAnti HIV Seropositive Pregnant Women

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Anti HIV seropositive Pregnant Women

Exclusion criteria

* Anti HIV seronegative Pregnant Women

Design outcomes

Primary

Measure	Time frame
The effect of the number of pregnancies on Anti HIV false positivity rate	5 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026